CIDP treatment: immunosuppressants
Evidence-based neurology checklist on cidp treatment: immunosuppressants: Steroids: benefits These are first line treatments if there are no contraindications They provide long term remission in a quarter of patients Steroids: options Rituximab Treatments with poor evidence Treatments to be…
Steroids: benefits
- These are first line treatments if there are no contraindications
- They provide long term remission in a quarter of patients
Steroids: options
Rituximab
Treatments with poor evidence
Treatments to be avoided
Investigational treatments
Scoring systems
Monitoring
Acronym
References
- Ripellino P, Fleetwood T, Cantello R, Comi C. Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations. Autoimmune Dis 2014; 2014:201657.
- Eftimov F, Vermeulen M, van Doorn PA, et al. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisone treatment. Neurology 2012; 78:1079-1084.
- van Schaik IN, Eftimov F, van Doorn PA, et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 2010; 9:245-253.
- Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, van Doorn PA. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. JNNP 2015; 86:1331-1336.
- Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol 2021 (Online ahead of print).
- And 7 more. Subscribe to see the full list
